KalGene Pharmaceuticals

0 followers


Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.

Industries

Headquarters

Stage

Employees

Links

Org chart

Nickolay V. Kukekov
President & CEO

Nickolay V. Kukekov

Collapse
Albert Agro
Acting Chief Medical Officer
Guriq S. Basi
Head of Preclinical Studies